Frequently Asked Questions

NuvaHealth connects you with licensed doctors who specialise in medical weight management. You complete a short health assessment, have a video consultation with a doctor, and receive a personalised treatment plan — all from home.

Every doctor on NuvaHealth is an independent Registered Medical Practitioner (RMP) verified through the National Medical Commission. They have specialist training in metabolic health, endocrinology, or internal medicine.

Your doctor will evaluate your health profile and may prescribe FDA-approved, evidence-based medications for weight management. The specific medication depends on your medical history, current health, and treatment goals. All prescribing decisions are made solely by your treating physician.

Yes. We take data protection seriously. All data is hosted on servers in India, encrypted with 256-bit encryption, and handled in compliance with the Digital Personal Data Protection (DPDP) Act. We never share your health information without your explicit consent.

Absolutely. NuvaHealth doctors can work alongside your existing healthcare team. We encourage you to share your NuvaHealth treatment plan with your primary care physician for coordinated care.

After your consultation, your doctor will share a personalised treatment plan. If medication is prescribed, it will be delivered to your door. You’ll have regular follow-up consultations to track progress and adjust your plan as needed.

Yes. Since consultations are conducted via video call and medications are delivered by courier, NuvaHealth is available across India. You just need a stable internet connection for your consultation.

PCOS is driven by insulin resistance — your cells absorb glucose poorly, so your body produces more insulin, which promotes fat storage (especially around the abdomen) and suppresses fat breakdown. Standard calorie-cutting diets work less well because the underlying hormonal environment resists weight loss. A doctor can address the metabolic root cause, not just calories.

Yes. Medical weight management for PCOS is evidence-based and largely driven by clinical assessment, lab review, nutrition planning, and prescription therapy where appropriate — all of which work well by video consultation. Your NMC-verified doctor can review your reports, prescribe digitally, and track your progress remotely.

Not mandatory for the first consultation. Your doctor may request common PCOS-relevant tests (fasting insulin, HbA1c, lipid profile, thyroid, vitamin D) after the initial review if they aren't already recent. Any pathology can be done locally in your city.

Realistic medical weight management for PCOS typically targets 0.5–1% of body weight per week initially. For a woman weighing 75 kg, that's 5–8 kg in the first 3 months, with cycle regularisation often seen by month two. Your doctor will set individualised targets based on your baseline.

Yes — but only once your TSH is well-controlled on medication. With optimal thyroid levels and a structured medical weight management plan, patients with hypothyroidism can lose weight at close to normal rates. The key is a doctor-led plan that accounts for your altered metabolism.

Levothyroxine corrects an underactive thyroid and may lead to 2–4 kg weight loss in the first few months as fluid retention resolves and metabolism normalises. But beyond this initial drop, further weight loss requires a proper medical weight management plan — levothyroxine alone does not cause ongoing weight loss.

Most doctors recheck TSH every 6–8 weeks during active weight loss, because significant weight changes can affect thyroid medication requirements. Your NuvaHealth doctor will guide you on timing and coordinate any dose adjustments.

Absolutely. Thyroid management is largely based on symptom review and lab reports — both of which work perfectly by video consultation. Any pathology (TSH, T3, T4) can be done locally, and your doctor can adjust medication digitally.

Yes, and this is one of the best-documented facts in diabetes research. Losing 5–7% of body weight returns blood sugar to normal in the majority of prediabetic adults and cuts progression to type 2 diabetes by more than half. Earlier action produces better outcomes.

Indian guidelines (and global ADA standards) define prediabetes as HbA1c 5.7–6.4% or fasting glucose 100–125 mg/dL. Above 6.5% HbA1c or 126 mg/dL fasting glucose crosses into diabetes. Your doctor can interpret your numbers in context.

That depends on your HbA1c, weight, family history, and other risk factors. Many Indians with prediabetes can reverse it with medical weight management alone; others benefit from a prescription alongside it. Your doctor will recommend based on your full profile.

HbA1c reflects 3-month average blood sugar, so meaningful changes take 8–12 weeks. Most patients on a structured medical weight loss plan see HbA1c drop 0.3–0.8% in the first three months, with further improvement as weight loss continues.

Most doctors recommend waiting 6 weeks after normal delivery and 8–12 weeks after C-section before any structured weight management begins, and only after your postnatal check-up. Your NuvaHealth doctor will assess your recovery and advise on the right time for your individual case.

Yes — gradual weight loss of up to 0.5 kg per week is considered safe during breastfeeding and does not affect milk supply for most women. Your doctor will calibrate calories, protein, and any prescriptions so your baby's nutrition is never compromised.

Pregnancy causes abdominal muscle separation (diastasis recti), hormonal shifts, and redistribution of visceral fat. Sleep deprivation and cortisol further promote belly fat storage. Medical weight management addresses these specific drivers rather than assuming standard post-diet approaches will work.

That's exactly why online consultation works well for new mothers — no clinic visits, no childcare arrangements, no waiting rooms. Book a time that suits your baby's routine, consult from home, and get prescriptions delivered.

They contain the same molecule, semaglutide, made by Novo Nordisk. The difference is dose and purpose: Ozempic is approved for type 2 diabetes at up to 2 mg, while Wegovy is approved for weight management at a higher 2.4 mg dose. Ozempic is often prescribed off-label for weight loss in India.

In the SURMOUNT-5 head-to-head trial, tirzepatide (Mounjaro) produced more weight loss than semaglutide — about 20.2% versus 13.7%. However, both are far more effective than dieting alone, individual responses vary, and the right choice depends on your medical history, tolerance and cost. It is a decision for your doctor.

In 2026, Mounjaro costs roughly Rs 13,000 to Rs 26,000 per month depending on dose, and Wegovy is in a broadly similar range. Exact cost depends on dose, supplier and pharmacy. Never buy from unverified online sellers, as counterfeit GLP-1 products are a real danger.

Switching is sometimes done under medical supervision — for example, because of side effects, cost, availability or an inadequate response. It is never something to do on your own; dosing, escalation schedules and timing all need a doctor's guidance.

Yes. All are Schedule H prescription medicines and require a valid prescription from a licensed doctor, dispensed by a licensed pharmacy. They are real medical treatments with real risks and are not safe to self-prescribe.

Yes. Mounjaro (tirzepatide) launched in India in March 2025 and is officially approved for type 2 diabetes and chronic weight management. It is sold on prescription as vials and pre-filled KwikPens, and must be dispensed by a licensed pharmacy.

As of 2026, Mounjaro costs roughly Rs 13,000 to Rs 14,000 per month at the 2.5 mg starting dose, around Rs 16,000 at 5 mg, and up to about Rs 26,000 at the highest doses. Vials are usually cheaper than KwikPens. It is an ongoing treatment, so the cost is a sustained monthly commitment.

In the SURMOUNT-1 trial, the 15 mg dose produced an average loss of around 21% of body weight over 72 weeks. Results vary between individuals and depend on dose, duration and lifestyle support. Weight is commonly regained if the medication is stopped without a maintenance plan.

Mounjaro is a once-weekly injection given under the skin of the abdomen, thigh or upper arm. Treatment starts at the lowest 2.5 mg dose and is increased gradually, usually every four weeks, under a doctor's supervision to limit side effects.

For appropriate patients under medical supervision, Mounjaro is considered effective and broadly well tolerated, with mostly mild-to-moderate gastrointestinal side effects. It carries rarer risks such as pancreatitis and is not suitable for people with a history of medullary thyroid cancer or pancreatitis. It requires a doctor's assessment, prescription and monitoring.

For most people, side effects such as nausea are worst in the first few weeks and after each dose increase, then ease as the body adapts. Many find the medication much easier to tolerate after the first one to two months. Slow dose escalation is the main reason side effects settle.

Eat smaller meals more often, stop eating as soon as you feel full, avoid greasy and fried foods, favour bland foods on bad days, and stay upright after eating. Most importantly, let your doctor escalate the dose slowly — rushing to a higher dose is the most common cause of bad nausea.

Rapid weight loss from any cause, including GLP-1 medication, removes some muscle along with fat. This can be limited by eating enough protein and doing regular strength training. Supervised weight-management programmes build muscle preservation into the plan deliberately.

It is a popular term for the hollowed, gaunt facial look that can follow rapid weight loss, as fat is lost from the face along with the rest of the body. It is not a unique drug effect — it is what fast fat loss does. Slower weight loss and preserving muscle reduce it.

Seek prompt medical care for severe or persistent abdominal pain (especially pain radiating to the back), persistent vomiting or dehydration, upper-right abdominal pain with fever or yellowing skin, signs of a severe allergic reaction, or a neck lump or persistent hoarseness. These are uncommon but need urgent attention.